Patel Anish

EDGAR CIK 0001967163

Enliven Therapeutics, Inc. - ELVN

Officer
CHIEF OPERATING OFFICER
Direct Buys
0
$0
0 Shares
Direct Sells
9
($534,022)
-34,125 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
4
($1.27) M
-50,716 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
10/18/2024
10b5-1
10/22/2024
Sell
-716 @ $30.00
($21,483) 343,311 (-0.21%) Indirect - See footnote
07/16/2024
10b5-1
07/16/2024
Sell
-1,547 @ $25.01
($38,692) 344,027 (-0.45%) Indirect - See footnote
07/15/2024
10b5-1
07/16/2024
Sell
-30,978 @ $25.05
($776,039) 345,574 (-8.23%) Indirect - See footnote
07/12/2024
10b5-1
07/16/2024
Sell
-17,475 @ $25.07
($438,095) 376,552 (-4.43%) Indirect - See footnote
04/08/2024
10b5-1
04/10/2024
Sell
-4,875 @ $18.60
($90,687) 2,597 (-65.24%) Direct
03/06/2024
10b5-1
03/08/2024
Sell
-4,875 @ $15.64
($76,239) 7,472 (-39.48%) Direct
02/06/2024
10b5-1
02/08/2024
Sell
-4,875 @ $15.11
($73,658) 12,347 (-28.31%) Direct
01/22/2024
10b5-1
01/24/2024
Sell
-4,875 @ $15.13
($73,783) 17,222 (-22.06%) Direct
01/02/2024
10b5-1
01/02/2024
Sell
-11,000 @ $15.00
($165,053) 22,097 (-33.24%) Direct
12/29/2023
10b5-1
01/02/2024
Sell
-20 @ $15.00
($300) 33,097 (-0.06%) Direct
12/28/2023
10b5-1
01/02/2024
Sell
-2,520 @ $15.08
($37,996) 33,117 (-7.07%) Direct
12/26/2023
10b5-1
12/27/2023
Sell
-102 @ $15.01
($1,531) 35,637 (-0.29%) Direct
12/22/2023
10b5-1
12/27/2023
Sell
-983 @ $15.03
($14,776) 35,739 (-2.68%) Direct